Neoplasms, Hematologic Completed Phase 1 Trials for Rituximab (DB00073)

Also known as: Hematological Neoplasm / Hematological Neoplasms / Hematologic Neoplasm / Hematologic Neoplasms / Haematological neoplasm / Malignant tumor of lymphoid hemopoietic and related tissue (disorder) / Haematological malignancy / Hematological malignancy / Hematologic neoplasm (disorder)

IndicationStatusPhase
DBCOND0056760 (Neoplasms, Hematologic)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02367196A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic CancersTreatment